Literature DB >> 2532538

Modulation of cell surface heparan sulfate structure by growth of cells in the presence of chlorate.

K M Keller1, P R Brauer, J M Keller.   

Abstract

Swiss mouse 3T3 cells, when grown in the presence of 5 mM chlorate, an inhibitor of PAPS synthesis, produce heparan sulfate glycosaminoglycan chains containing only about 8% of the sulfate normally present and which have lost the ability to bind to fibronectin. These undersulfated chains are sensitive to nitrous acid at pH 4.5, indicating that many glucosaminyl residues have unsubstituted amino groups. The iduronic acid content of the heparan sulfate produced in the presence of chlorate is reduced to less than 7% as compared to the 36% in that from untreated cells. The chlorate-treated cells do not demonstrate any alterations in their growth control. However, the spreading behavior of these cells is altered to a flat rounded morphology compared to the more typical fibroblastic appearance of the untreated cell. The sulfation of chondroitin chains is also inhibited, but at a lower chlorate concentration which does not alter growth control or the spreading ability of the cells. These data indicate that (a) 3T3 cell surface heparan sulfate proteoglycan is not involved in growth control but may be involved in cell spreading, (b) the use of chlorate should be a valuable method for the study of the biosynthesis and structure/function relationships of sulfated glycosaminoglycans, and (c) the temporal sequence of the heparan sulfate chain modification reactions predicted from results of studies with cell-free extracts also operates in the cell.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2532538     DOI: 10.1021/bi00446a021

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  26 in total

1.  Re-examination of CD91 function in GRP94 (glycoprotein 96) surface binding, uptake, and peptide cross-presentation.

Authors:  Angela R Jockheck-Clark; Edith V Bowers; Mariam B Totonchy; Julie Neubauer; Salvatore V Pizzo; Christopher V Nicchitta
Journal:  J Immunol       Date:  2010-11-03       Impact factor: 5.422

2.  The N-terminal Arg2, Arg3 and Arg4 of human lactoferrin interact with sulphated molecules but not with the receptor present on Jurkat human lymphoblastic T-cells.

Authors:  D Legrand; P H van Berkel; V Salmon; H A van Veen; M C Slomianny; J H Nuijens; G Spik
Journal:  Biochem J       Date:  1997-11-01       Impact factor: 3.857

3.  The major fimbrial subunit of Bordetella pertussis binds to sulfated sugars.

Authors:  C A Geuijen; R J Willems; F R Mooi
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

4.  Interaction of Escherichia coli heat-stable enterotoxin B with cultured human intestinal epithelial cells.

Authors:  K L Chao; L A Dreyfus
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

5.  Effect of long-term treatment of 3T3-L1 adipocytes with chlorate on the synthesis, glycosylation, intracellular transport and secretion of lipoprotein lipase.

Authors:  H Masuno; K Sakayama; H Okuda
Journal:  Biochem J       Date:  1998-02-01       Impact factor: 3.857

6.  Cysteine-rich domain of human ADAM 12 (meltrin alpha) supports tumor cell adhesion.

Authors:  K Iba; R Albrechtsen; B J Gilpin; F Loechel; U M Wewer
Journal:  Am J Pathol       Date:  1999-05       Impact factor: 4.307

7.  Heparin-binding EGF-like growth factor stimulation of smooth muscle cell migration: dependence on interactions with cell surface heparan sulfate.

Authors:  S Higashiyama; J A Abraham; M Klagsbrun
Journal:  J Cell Biol       Date:  1993-08       Impact factor: 10.539

8.  Involvement of wound-associated factors in rat brain astrocyte migratory response to axonal injury: in vitro simulation.

Authors:  A Faber-Elman; A Solomon; J A Abraham; M Marikovsky; M Schwartz
Journal:  J Clin Invest       Date:  1996-01-01       Impact factor: 14.808

9.  6-o- and N-sulfated syndecan-1 promotes baculovirus binding and entry into Mammalian cells.

Authors:  Kaisa-Emilia Makkonen; Paula Turkki; Johanna P Laakkonen; Seppo Ylä-Herttuala; Varpu Marjomäki; Kari J Airenne
Journal:  J Virol       Date:  2013-08-07       Impact factor: 5.103

10.  The anticancer activity of lytic peptides is inhibited by heparan sulfate on the surface of the tumor cells.

Authors:  Bodil Fadnes; Oystein Rekdal; Lars Uhlin-Hansen
Journal:  BMC Cancer       Date:  2009-06-15       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.